6-Mercaptopurine in psoriatic arthritis

R. Tur Kaspa, M. Ehrenfield, M. Eliakin

Research output: Contribution to journalArticlepeer-review


Three patients with psoriatic arthritis who did not respond to nonsteroidal analgetics were treated with 6-mercaptopurine. Remissions lasting 6-24 months were achieved in all cases. Cessation of therapy resulted in exacerbation of symptoms in two of the cases. In view of the low incidence of side effects, 6-mercaptopurine seems to have a place in the treatment of selected cases of psoriatic arthritis.

Original languageEnglish
Pages (from-to)648-649+690
Issue number12
StatePublished - 1979
Externally publishedYes


Dive into the research topics of '6-Mercaptopurine in psoriatic arthritis'. Together they form a unique fingerprint.

Cite this